Dolat Capital is bullish on Sun Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 530 in its research report dated May 27, 2020.
ICICI Securities is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 528 in its research report dated May 27, 2020.
Prabhudas Lilladher recommended hold rating on Sun Pharmaceutical Industries with a target price of Rs 436 in its research report dated May 21, 2020.
Sharekhan recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 460 in its research report dated November 13, 2019.
ICICI Direct recommended hold rating on Sun Pharmaceutical Industries with a target price of Rs 470 in its research report dated August 14, 2019.
HDFC Securities is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 545 in its research report dated August 14, 2019.
Sharekhan recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 500 in its research report dated August 13, 2019.
ICICI Direct recommended hold rating on Sun Pharmaceutical Industries with a target price of Rs 460 in its research report dated May 29, 2019.
Sharekhan recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 460 in its research report dated May 28, 2019.
HDFC Securities is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 600 in its research report dated May 29, 2019.
ICICI Direct recommended hold rating on Sun Pharmaceuticals with a target price of Rs 460 in its research report dated February 13, 2019.
Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 540 in its research report dated February 12, 2019.
Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 560 in its research report dated January 22, 2019.
ICICI Direct recommended hold rating on Sun Pharmaceuticals with a target price of Rs 460 in its research report dated December 04, 2018.
Sharekhan recommended Hold rating on Sun Pharma with a target price of Rs 525 in its research report dated December 04, 2018.
Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 760 in its research report dated November 13, 2018.
HDFC Securities is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 670 in its research report dated November 14, 2018.
Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 790 in its research report dated September 19, 2018.
Centrum recommended hold rating on Sun Pharma with a target price of Rs 580 in its research report dated September 17, 2018.
Motilal Oswal is bullish on Sun Pharma has recommended Buy rating on the stock with a target price of Rs 790 in its research report dated September 07, 2018.
HDFC Securities is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 670 in its research report dated August 16, 2018.
ICICI Direct is bullish on Sun Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 690 in its research report dated August 16, 2018.
We continue to like the strong domestic business of Sun and the niche that it is trying to create with speciality in the US.
Geojit recommended hold rating on Sun Pharmaceutical Industries with a target price of Rs 597 in its research report dated June 19, 2018.
